Cisplatin selectively downregulated the frequency and immunoinhibitory function of myeloid-derived suppressor cells in a murine B16 melanoma model (Q86757302)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 February 2016

Language	Label	Description	Also known as
English	Cisplatin selectively downregulated the frequency and immunoinhibitory function of myeloid-derived suppressor cells in a murine B16 melanoma model	scientific article published on 01 February 2016

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26590944%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Cisplatin selectively downregulated the frequency and immunoinhibitory function of myeloid-derived suppressor cells in a murine B16 melanoma model (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26590944%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference

based on heuristic

inferred from title

author name string

Xiang Huang

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26590944%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Shiyun Cui

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26590944%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Yongqian Shu

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26590944%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

publication date

1 February 2016

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26590944%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Immunologic Research

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26590944%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

64

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26590944%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26590944%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

160-170

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26590944%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Myeloid-derived suppressor cells in cancer patients: a clinical perspective.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26590944

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rosiglitazone and Gemcitabine in combination reduces immune suppression and modulates T cell populations in pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/26590944

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/26590944

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IL4Ralpha+ myeloid-derived suppressor cell expansion in cancer patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26590944

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Myeloid derived suppressor cells-An overview of combat strategies to increase immunotherapy efficacy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26590944

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Next Hurdle in Cancer Immunotherapy: Overcoming the Non-T-Cell-Inflamed Tumor Microenvironment

1 reference

https://pubmed.ncbi.nlm.nih.gov/26590944

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness and safety of chemotherapy combined with dendritic cells co-cultured with cytokine-induced killer cells in the treatment of advanced non-small-cell lung cancer: a systematic review and meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/26590944

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergy between chemotherapeutic agents and CTLA-4 blockade in preclinical tumor models

1 reference

https://pubmed.ncbi.nlm.nih.gov/26590944

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment

1 reference

https://pubmed.ncbi.nlm.nih.gov/26590944

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low-dose cyclophosphamide administered as daily or single dose enhances the antitumor effects of a therapeutic HPV vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/26590944

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New clinical advances in immunotherapy for the treatment of solid tumours.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26590944

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preconditioning chemotherapy with paclitaxel and cisplatin enhances the antitumor activity of cytokine induced‐killer cells in a murine lung carcinoma model

1 reference

https://pubmed.ncbi.nlm.nih.gov/26590944

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer immunotherapy and breaking immune tolerance: new approaches to an old challenge.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26590944

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cisplatin pretreatment enhances anti-tumor activity of cytokine-induced killer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/26590944

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The restoration of myeloid-derived suppressor cells as functional antigen-presenting cells by NKT cell help and all-trans-retinoic acid treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/26590944

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Highlights on mechanisms of drugs targeting MDSCs: providing a novel perspective on cancer treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/26590944

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The blockade of immune checkpoints in cancer immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26590944

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor-induced myeloid dysfunction and its implications for cancer immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26590944

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunosuppressive myeloid-derived suppressor cells can be converted into immunogenic APCs with the help of activated NKT cells: an alternative cell-based antitumor vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/26590944

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A novel chemoimmunomodulating property of docetaxel: suppression of myeloid-derived suppressor cells in tumor bearers.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26590944

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Generation of a new therapeutic peptide that depletes myeloid-derived suppressor cells in tumor-bearing mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/26590944

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preconditioning chemotherapy with cisplatin enhances the antitumor activity of cytokine-induced killer cells in a murine melanoma model

1 reference

https://pubmed.ncbi.nlm.nih.gov/26590944

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergy between T-cell immunity and inhibition of paracrine stimulation causes tumor rejection

1 reference

https://pubmed.ncbi.nlm.nih.gov/26590944

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Myeloid-derived suppressor cells: Cellular missiles to target tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/26590944

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26590944

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Myeloid-derived suppressor cells in cancer: therapeutic, predictive, and prognostic implications

1 reference

https://pubmed.ncbi.nlm.nih.gov/26590944

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Myeloid-derived suppressor cells in cancer: recent progress and prospects.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26590944

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of myeloid-derived suppressor cells in tumor immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26590944

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer immunotherapy comes of age

1 reference

https://pubmed.ncbi.nlm.nih.gov/26590944

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hampering immune suppressors: therapeutic targeting of myeloid-derived suppressor cells in cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/26590944

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens

1 reference

https://pubmed.ncbi.nlm.nih.gov/26590944

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Doxorubicin eliminates myeloid-derived suppressor cells and enhances the efficacy of adoptive T-cell transfer in breast cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26590944

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/26590944

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Challenges and future perspectives of T cell immunotherapy in cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/26590944

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aptamer-mediated blockade of IL4Rα triggers apoptosis of MDSCs and limits tumor progression

1 reference

https://pubmed.ncbi.nlm.nih.gov/26590944

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Checkpoint blockade in cancer immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26590944

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/26590944

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/26590944

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunosuppressive networks and checkpoints controlling antitumor immunity and their blockade in the development of cancer immunotherapeutics and vaccines.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26590944

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PD-1 pathway inhibitors: changing the landscape of cancer immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26590944

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q86757302&oldid=2221869869"